Meta AnalysisID 7709
碘-125放射性粒子组织间植入治疗晚期肺癌的疗效与安全性：一项Meta分析
CRD42023469721
P: lung cancer, NSCLC I: 125I brachytherapy with chemotherapy C: chemotherapy O: complete response rate, disease control rate, 1-year survival rate, 2-year survival rate, 3-year survival rate, progress free survival (PFS
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Ingredient: 1Meta-analysis: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final meta_analysis record.
- Meta Analysis Id
- 7709
- Evidence Id
- 16267
- Core Evidence Id
- 16267
- Source Meta Analysis Id
- 7703
- Herb2 Meta Analysis Id
- HBMA007703
- Crd Id
- CRD42023469721
- Title
- Efficacy and safety of iodine-125 radioactive seeds brachytherapy for advanced lung cancer: a meta-analysis
- Review Question
- P: lung cancer, NSCLC I: 125I brachytherapy with chemotherapy C: chemotherapy O: complete response rate, disease control rate, 1-year survival rate, 2-year survival rate, 3-year survival rate, progress free survival (PFS) S: RCT
- Study Type Included
- RCTs
- Condition Being Studied
- According to the Global Cancer Statistics 2020 report, lung cancer is the second prevalent malignancy, causing 11.4% of all malignant tumors, but it remains the leading cause of cancer fatalities, accounting for approximately 1.8 million deaths (18%), with non-small cell lung cancer (NSCLC) accounting for 85% of these deaths
- Participant
- 1 Diagnosis of NSCLC by histology or pathology. 2 The diagnosis of NSCLC was confirmed by histology or pathology. 3 TNM stage IIb-IV non-small cell lung cancer according to the 7th edition of the AJCC 2010; 4 Age greater than 18 years. 4 Age greater than 18 years.
- Animal
- Human Disease Modelled
- Intervention
- 125I brachytherapy with chemotherapy
- Comparator Control
- chemotherapy
- Main Outcome
- complete response rate (CRR), disease control rate (DCR), 1-year survival rate, 2-year survival rate, 3-year survival rate
- Outcome Measure
- Additional Outcome
- progress free survival (PFS), and treatment-related toxicity
- Study Method
- Meta-analysis, Systematic review
- Keyword
- Brachytherapy; Carcinoma, Non-Small-Cell Lung; Humans; Iodine-125; Lung Neoplasms; Randomized Controlled Trials as Topic; Survival Rate
- Contact
- hanming yu [email protected]
- Organisational Affiliation
- The fourth Affiliated Hospital of Chinese medicine University
- Funding Source
- Other Selection Criteria
- Final Publication
- Same Topic Review
- Published Protocol
- Review Type
- Language
- English
- Country
- China
- Review Stage
- Review Ongoing
- First Submission Date
- 2023-10-05
- Registration Date
- 2023-10-16
- Anticipated Start Date
- 2023-10-07
- Anticipated Completion Date
- 2023-11-07
- Title Cn
- 碘-125放射性粒子组织间植入治疗晚期肺癌的疗效与安全性：一项Meta分析
- Title En
- Efficacy and safety of iodine-125 radioactive seeds brachytherapy for advanced lung cancer: a meta-analysis
- Bilingual Status
- complete